Back
MetLife Inc (MET)
InsuranceMET · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$95.89
−0.32%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$5.02
ROE
13.0%
Gross margin
23.8%
Debt/Equity
1.78x
Revenue growth
2.7%
MetLife Inc — company intelligence
Earnings surprises
Q2 2026$2.43 vs $2.32 est+4.9%
Q1 2026$2.42 vs $2.29 est+5.5%
Q4 2025$2.58 vs $2.37 est+9.1%
Q3 2025$2.37 vs $2.34 est+1.2%
Analyst consensus · 24 analysts
17 Buy7 Hold0 Sell
Updated Aug 22, 2026
Insider activity · 90 days
19 buys1 sellnet -13,548 shares
HUBBARD ROBERT GLENNBuy 1,016 · Jun 16, 2026
Mumenthaler Christian StephaneBuy 587 · Jun 16, 2026
Johnson Jeh C.Buy 587 · Jun 16, 2026
Recent SEC filings
8-K — Material event reportAug 17, 2026
10-Q — Quarterly reportAug 6, 2026
8-K — Material event reportAug 5, 2026
Latest news
Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $109 — Benzinga · 6d ago
MetLife’s Q2 Earnings Call: Our Top 5 Analyst Questions — Yahoo · 1w ago
MetLife (MET) Q2 2026 Earnings Call Transcript — Yahoo · 1w ago
MetLife 2025 Sustainability Report: Benefits and Well-Being — Yahoo · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.